Toboroz
Biomarker Targeted Stimulation for Epileptiform Events
NCT06424977· Cadence Neuroscience· Forrás
Contact: Mariana Gallardo
Toboroz
A Study of Olezarsen for the Treatment of Familial Chylomicronemia Syndrome (FCS) in Pediatric Participants
NCT07727538· 3. fázis· Ionis Pharmaceuticals, Inc.· Forrás
Contact: Ionis Pharmaceuticals, Inc.
Toboroz
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
NCT07586618· 1. fázis· Allterum Therapeutics, Inc· Forrás
Contact: Heather Jernigan
Toboroz
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
NCT06900595· 2. fázis· National Cancer Institute (NCI)· Forrás
Contact: Kelly L. Vallance (principal investigator)
Toboroz
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
NCT07187531· 2. fázis· SAb Biotherapeutics, Inc.· Forrás
Contact: Tiffany Skrodzi
Toboroz
A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
NCT07112378· 3. fázis· Regeneron Pharmaceuticals· Forrás
Contact: Clinical Trials Administrator
Toboroz
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
NCT07047144· 2. fázis· Scholar Rock, Inc.· Forrás
Contact: Kayla Blough
Toboroz
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
NCT06317662· 2. fázis· National Cancer Institute (NCI)· Forrás
Contact: Holly Pacenta (principal investigator)
Fut, nem toboroz
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome
NCT06872125· 3. fázis· Stoke Therapeutics, Inc· Forrás
Toboroz
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
NCT06124157· 2. fázis· National Cancer Institute (NCI)· Forrás
Contact: Kenneth M. Heym (principal investigator)
Toboroz
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
NCT06401330· 3. fázis· Children's Oncology Group· Forrás
Contact: Kelly L. Vallance (principal investigator)
Toboroz
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
NCT06647953· 3. fázis· Children's Oncology Group· Forrás
Contact: Kelly L. Vallance (principal investigator)
Toboroz
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
NCT06513962· 3. fázis· Children's Oncology Group· Forrás
Contact: Karen H. Albritton (principal investigator)
Toboroz
NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
NCT06450041· 2. fázis· New Approaches to Neuroblastoma Therapy Consortium· Forrás
Contact: Chelsee Greer, DO
Toboroz
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
NCT06410209· 2. fázis· Children's Oncology Group· Forrás
Contact: Donald T. Beam (principal investigator)
Toboroz
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
NCT06504589· Nicole Hamblett· Forrás
Contact: Anna Reyes
Toboroz
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
NCT05711667· 3. fázis· Children's Oncology Group· Forrás
Contact: Richard P. Howrey (principal investigator)
Toboroz
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
NCT06064097· 2. fázis· National Cancer Institute (NCI)· Forrás
Contact: Chelsee Greer (principal investigator)
Toboroz
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
NCT06056297· 3. fázis· X4 Pharmaceuticals· Forrás
Contact: Patient Affairs and Advocacy
Toboroz
A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
NCT05419492· 1/2. fázis· Encoded Therapeutics· Forrás
Contact: Neurology Epilepsy Research
Toboroz
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
NCT06172296· 3. fázis· National Cancer Institute (NCI)· Forrás
Contact: Chelsee Greer (principal investigator)
Toboroz
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
NCT06177067· 1. fázis· St. Jude Children's Research Hospital· Forrás
Contact: Holly Pacenta, MD
Toboroz
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
NCT05509777· 3. fázis· Eli Lilly and Company· Forrás
Contact: Clifton Huang (principal investigator)
Toboroz
Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease
NCT06023641· 2. fázis· St. Jude Children's Research Hospital· Forrás
Contact: Karen Albritton, MD
Fut, nem toboroz
A Study of Revumenib in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia
NCT05761171· 2. fázis· Children's Oncology Group· Forrás
Toboroz
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
NCT05702645· Children's Oncology Group· Forrás
Contact: Donald T. Beam (principal investigator)
Fut, nem toboroz
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
NCT05602194· 3. fázis· Children's Oncology Group· Forrás
Toboroz
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
NCT05705531· Children's Oncology Group· Forrás
Contact: Donald T. Beam (principal investigator)
Toboroz
Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy
NCT05865301· Stanford University· Forrás
Contact: Holly Pacenta
Toboroz
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
NCT05675410· 3. fázis· National Cancer Institute (NCI)· Forrás
Contact: Karen H. Albritton (principal investigator)
Toboroz
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
NCT05548283· 4. fázis· Chris Goss· Forrás
Contact: Jill Finto
Fut, nem toboroz
Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome
NCT05457556· 3. fázis· Children's Oncology Group· Forrás
Fut, nem toboroz
ABTECT - Maintenance
NCT05535946· 3. fázis· Abivax S.A.· Forrás
Toboroz
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
NCT05535166· 2. fázis· St. Jude Children's Research Hospital· Forrás
Contact: Sibo Zhao, MD
Toboroz
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
NCT05287126· 2. fázis· Pfizer· Forrás
Fut, nem toboroz
Rapid Administration Pilot for Infusing Dinutuximab
NCT05421897· 2. fázis· Children's Hospital Los Angeles· Forrás
Fut, nem toboroz
Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors
NCT05286801· 1/2. fázis· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
Vincristine Pharmacokinetics in Infants
NCT05359237· Children's Oncology Group· Forrás
Fut, nem toboroz
A Study of EDG-5506 in Children With Duchenne Muscular Dystrophy (LYNX)
NCT05540860· 2. fázis· Edgewise Therapeutics, Inc.· Forrás
Toboroz
GABA Biomarkers in Dravet Syndrome
NCT05651204· Cook Children's Health Care System· Forrás
Contact: Sabrina Shandley, PhD
Fut, nem toboroz
A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow
NCT05330325· 3. fázis· Novo Nordisk A/S· Forrás
Toboroz
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
NCT05304585· 3. fázis· Children's Oncology Group· Forrás
Contact: Kelly L. Vallance (principal investigator)
Fut, nem toboroz
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
NCT05099003· 1/2. fázis· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
A Study to See if Memantine Protects the Brain During Radiation Therapy Treatment for a Brain Tumor
NCT04939597· 3. fázis· Children's Oncology Group· Forrás
Toboroz
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
NCT04726241· 1/2. fázis· PedAL BCU, LLC· Forrás
Contact: Holly Pacenta (principal investigator)
Toboroz
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
NCT05235165· 3. fázis· Children's Oncology Group· Forrás
Contact: Karen H. Albritton (principal investigator)
Toboroz
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
NCT04870944· 1/2. fázis· Children's Oncology Group· Forrás
Contact: Sibo Zhao (principal investigator)
Fut, nem toboroz
Elimusertib for the Treatment of Relapsed or Refractory Solid Tumors
NCT05071209· 1/2. fázis· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
Study of Selinexor and Venetoclax in Combination With Chemotherapy in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia
NCT04898894· 1. fázis· St. Jude Children's Research Hospital· Forrás
Toboroz
Robot-assisted Training in Children With CP
NCT06450158· Cook Children's Health Care System· Forrás
Contact: Sadra Shahdadian, PhD
Showing 50 of 102.